Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions.

Count outcomes Interrupted time series Policy evaluation Power Quasi-experimental design Sample size calculation Segmented regression

Journal

Contemporary clinical trials communications
ISSN: 2451-8654
Titre abrégé: Contemp Clin Trials Commun
Pays: Netherlands
ID NLM: 101671157

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 01 07 2019
revised: 08 09 2019
accepted: 14 10 2019
entrez: 31 12 2019
pubmed: 31 12 2019
medline: 31 12 2019
Statut: epublish

Résumé

The purpose of this study was to present the design, model, and data analysis of an interrupted time series (ITS) model applied to evaluate the impact of health policy, systems, or environmental interventions using count outcomes. Simulation methods were used to conduct power and sample size calculations for these studies. We proposed the models and analyses of ITS designs for count outcomes using the Strengthening Translational Research in Diverse Enrollment (STRIDE) study as an example. The models we used were observation-driven models, which bundle a lagged term on the conditional mean of the outcome for a time series of count outcomes. A simulation-based approach with ready-to-use computer programs was developed to calculate the sample size and power of two types of ITS models, Poisson and negative binomial, for count outcomes. Simulations were conducted to estimate the power of segmented autoregressive (AR) error models when autocorrelation ranged from -0.9 to 0.9, with various effect sizes. The power to detect the same magnitude of parameters varied largely, depending on the testing level change, the trend change, or both. The relationships between power and sample size and the values of the parameters were different between the two models. This article provides a convenient tool to allow investigators to generate sample sizes that will ensure sufficient statistical power when the ITS study design of count outcomes is implemented.

Identifiants

pubmed: 31886433
doi: 10.1016/j.conctc.2019.100474
pii: S2451-8654(19)30236-4
pii: 100474
pmc: PMC6920506
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100474

Subventions

Organisme : NCATS NIH HHS
ID : U01 TR001812
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001453
Pays : United States

Informations de copyright

© 2019 The Authors.

Déclaration de conflit d'intérêts

None.

Références

Med Care Res Rev. 2018 Jan 01;:1077558717751941
pubmed: 29347864
Accid Anal Prev. 2013 Mar;52:204-9
pubmed: 23339779
Med Care. 2018 May;56(5):382-383
pubmed: 29634630
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
Biometrics. 1988 Dec;44(4):1019-31
pubmed: 3148334
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Med Care. 2018 May;56(5):365-372
pubmed: 29634627
Stat Med. 2017 Dec 20;36(29):4660-4676
pubmed: 28850683
J Eval Clin Pract. 2011 Dec;17(6):1231-8
pubmed: 20973870
Cancer. 2008 Jan 15;112(2):228-42
pubmed: 18008363
J Clin Epidemiol. 2011 Nov;64(11):1252-61
pubmed: 21640554
Prev Sci. 2000 Mar;1(1):31-49
pubmed: 11507793
Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):18-24
pubmed: 24745811
Am J Public Health. 2014 Feb;104(2):e16-31
pubmed: 24328648
J Clin Epidemiol. 2013 Aug;66(8):883-7
pubmed: 23810027

Auteurs

Wei Liu (W)

School of Management, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.

Shangyuan Ye (S)

Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, 02115, USA.

Bruce A Barton (BA)

School of Management, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.

Melissa A Fischer (MA)

Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA, 01605, USA.

Colleen Lawrence (C)

Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.

Elizabeth J Rahn (EJ)

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Maria I Danila (MI)

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Kenneth G Saag (KG)

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Paul A Harris (PA)

Department of Biomedical Informatics and Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37203, USA.

Stephenie C Lemon (SC)

School of Management, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.

Jeroan J Allison (JJ)

School of Management, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China.

Bo Zhang (B)

Department of Neurology and ICCTR Biostatistics and Research Design Center, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02215, USA.

Classifications MeSH